CETIRIZINE HYDROCHLORIDE HIVES RELIEF

Post-LOE

cetirizine

Ichnos Glenmark Innovation

ANDAORALTABLET

Approved

Jan 2010

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

CETIRIZINE HYDROCHLORIDE HIVES RELIEF (cetirizine) by Ichnos Glenmark Innovation is histamine h1 receptor antagonists [moa]. Approved for these symptoms due to hay fever, other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose and 1 more indications. First approved in 2010.

Drug data last refreshed 18h ago

Mechanism of Action

Histamine H1 Receptor Antagonists

Indications (4)

these symptoms due to hay fever other upper respiratory allergies: runny nose sneezing itchy watery eyes itching of the nose

Worked on CETIRIZINE HYDROCHLORIDE HIVES RELIEF at Ichnos Glenmark Innovation? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Clinical Trials (20)

NCT04189588Phase 2Completed

Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine

Started Mar 2020

34 enrolled

Oncology Patients Receiving Chemotherapy

NCT04175834Phase 3Completed

Comparing Risk and Severity of IRRs in Patients Premedicated With Cetirizine vs. Diphenhydramine Prior to Ocrelizumab

Started Feb 2020

19 enrolled

Multiple SclerosisInfusion Reaction

NCT03772158Phase 1Completed

Cetirizine Chewable Bioequivalence and Food Effect Study

Started Dec 2018

40 enrolled

Allergy

NCT03555890Phase 1Completed

Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT)

Started May 2018

72 enrolled

Rhinitis

NCT03340740Phase 4Completed

The Effect of Cetirizine on Bronchoconstriction

Started May 2018